While the level of statistical significance was the same, the two estimates convey different interpretations: one expressed a 2% increase in the odds of delirium incidence per one pg/ml increase in IL-6, and the other yielded an estimate of the population median difference of IL-6 between delirium cases and controls on POD2. The gene discussed is IL6; the disease is delirium.